IL-6, a common SASP factor, is upregulated following chemoradiation and has been shown to be required for glioma development from glioma stem cells in a mouse model71, which may be of use for cancer cells that have acquired stemness after senescence induced by chemotherapy8. The gene discussed is IL6; the disease is central nervous system cancer.